ENTRY       D10264            Mixture   Drug
NAME        Linagliptin and metformin hydrochloride;
            Jentaduet (TN)
PRODUCT     JENTADUETO (Boehringer Ingelheim Pharmaceuticals)
            JENTADUETO XR (Boehringer Ingelheim Pharmaceuticals)
COMPONENT   Linagliptin [DR:D09566], Metformin hydrochloride [DR:D00944]
CLASS       Antidiabetic agent
             DG02044  Hypoglycemic agent
              DG03032  Combination of metformin and DPP-4 inhibitor
            Transporter substrate
             DG01665  ABCB1 substrate
REMARK      ATC code: A10BD11
            Product: D10264<US>
EFFICACY    Antidiabetic
  DISEASE   Type 2 diabetes mellitus [DS:H00409]
COMMENT     Linagliptin is a P-glycoprotein (P-gp) substrate.
METABOLISM  Transporter: ABCB1 [HSA:5243]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A10 DRUGS USED IN DIABETES
               A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
                A10BD Combinations of oral blood glucose lowering drugs
                 A10BD11 Metformin and linagliptin
                  D10264  Linagliptin and metformin hydrochloride &lt;US&gt;
            USP drug classification [BR:br08302]
             Blood Glucose Regulators
              Antidiabetic Combinations
               Linagliptin/ Metformin Hydrochloride
                D10264  Linagliptin and metformin hydrochloride
            Drug groups [BR:br08330]
             Antidiabetic agent
              DG02044  Hypoglycemic agent
               DG03032  Combination of metformin and DPP-4 inhibitor
                D10264  Linagliptin and metformin hydrochloride
             Transporter substrate
              DG01665  ABCB1 substrate
               D10264  Linagliptin and metformin hydrochloride
            Drug classes [BR:br08332]
             Antidiabetic agent
              DG02044  Hypoglycemic agent
               D10264  Linagliptin and metformin hydrochloride
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10264
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug transporters
              D10264
DBLINKS     PubChem: 163312295
///
